相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Platinum-based drugs for cancer therapy and anti-tumor strategies
Chunyu Zhang et al.
THERANOSTICS (2022)
MiR-192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF-κB pathway
Yang Li et al.
THORACIC CANCER (2022)
The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: Therapeutic implications
Priya Mondal et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2022)
The regulation of autophagy by the miR-199a-5p/p62 axis was a potential mechanism of small cell lung cancer cisplatin resistance
Tiezhi Li et al.
CANCER CELL INTERNATIONAL (2022)
Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance
Han-Ying Cheng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Increased PD-L1 Expression in Acquired Cisplatin-Resistant Lung Cancer Cells via Mir-181a
Yingying Chen et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2022)
The long intergenic noncoding RNA GAS5 reduces cisplatin-resistance in non-small cell lung cancer through the miR-217/LHPP axis
Xuhui Yang et al.
AGING-US (2021)
Long non-coding RNA LINC01224 promotes progression and cisplatin resistance in non-small lung cancer by sponging miR-2467
Shumei Xiao et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2021)
A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinoma
Alvaro Gonzalez Rajal et al.
ELIFE (2021)
microRNAs in cancer chemoresistance: The sword and the shield
Priya Mondal et al.
NON-CODING RNA RESEARCH (2021)
Up-regulation of microRNA miR-101-3p enhances sensitivity to cisplatin via regulation of small interfering RNA (siRNA) Anti-human AGT4D and autophagy in non-small-cell lung carcinoma (NSCLC)
Dong Cui et al.
BIOENGINEERED (2021)
The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Jiabei Zhou et al.
FRONTIERS IN PHARMACOLOGY (2020)
Long non-coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR-514a-3p/ULK1 axis in human non-small cell lung cancer
Qiming Shen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Long non-coding RNAs in breast cancer metastasis
Priya Mondal et al.
NON-CODING RNA RESEARCH (2020)
撤稿声明: miR-451 selectively increases sensitivity to cisplatin in ERCC1-high non-small cell lung cancer cells (Retraction of 2017)
Kaihua Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
MiR-494 acts as a tumor promoter by targeting CASP2 in non-small cell lung cancer
Qiao Zhang et al.
SCIENTIFIC REPORTS (2019)
microRNA-1236-3p regulates DDP resistance in lung cancer cells
Zhigang Wang et al.
OPEN MEDICINE (2019)
Application of PD-1 Blockade in Cancer Immunotherapy
Xiaomo Wu et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Long non-coding RNA LINC00485 acts as a microRNA-195 sponge to regulate the chemotherapy sensitivity of lung adenocarcinoma cells to cisplatin by regulating CHEK1
Wei Zuo et al.
CANCER CELL INTERNATIONAL (2019)
MicroRNA-152 suppresses cisplatin resistance in A549 cells
Wenfei Zhao et al.
ONCOLOGY LETTERS (2019)
LncRNA SNHG1 upregulates ROCK2 to reduce cisplatin sensitivity of NSCLC cells by targeting miR-101-3p
Lei Wei et al.
TRANSLATIONAL CANCER RESEARCH (2019)
Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p
Lin-Juan Tian et al.
MEDICAL SCIENCE MONITOR (2019)
LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis
Linmei Wang et al.
CANCER BIOLOGY & THERAPY (2019)
Non-coding RNAs in Lung Cancer Chemoresistance
Priya Mondal et al.
CURRENT DRUG METABOLISM (2019)
MicroRNA-29a enhances cisplatin sensitivity in non-small cell lung cancer through the regulation of REV3L
Xialin Chen et al.
MOLECULAR MEDICINE REPORTS (2019)
LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation
Zhixian Fang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP)
Wenfeng Tan et al.
CANCER LETTERS (2018)
MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/-catenin pathway
Qiang Zhang et al.
CELL BIOCHEMISTRY AND FUNCTION (2018)
miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells
Chen Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway
Jiangang Liu et al.
ONCOLOGY REPORTS (2018)
Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR
Bin Li et al.
ONCOLOGY REPORTS (2018)
MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer
Xin Liu et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2018)
Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a
Yanqin Sun et al.
CELL DEATH & DISEASE (2018)
MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2
Ming-Jenn Chen et al.
Oncotarget (2018)
MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway
Dian-min Sun et al.
SCIENTIFIC REPORTS (2018)
Negative Regulation of PTEN by MicroRNA-221 and Its Association with Drug Resistance and Cellular Senescence in Lung Cancer Cells
Ning Wang et al.
BIOMED RESEARCH INTERNATIONAL (2018)
LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3
Xia Zhao et al.
CANCER SCIENCE (2018)
Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer
Xinju Zhang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2018)
Base and nucleotide excision repair facilitate resolution of platinum drugs-induced transcription blockage
Jana Slyskova et al.
NUCLEIC ACIDS RESEARCH (2018)
Comparison of efficacy and toxicity between nedaplatin and cisplatin in treating malignant pleural effusion
Li-Zhe Zhong et al.
ONCOTARGETS AND THERAPY (2018)
MicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2
Qiaoling Pan et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Suppression of EIF4G2 by miR-379 potentiates the cisplatin chemosensitivity in nonsmall cell lung cancer cells
Guang-jun Hao et al.
FEBS LETTERS (2017)
Long non-coding RNA AK001796 contributes to cisplatin resistance of non-small cell lung cancer
Bin Liu et al.
MOLECULAR MEDICINE REPORTS (2017)
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
Peter M. Bruno et al.
NATURE MEDICINE (2017)
Downregulation of miR-218 contributes to epithelialmesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling
Z-M Shi et al.
ONCOGENE (2017)
LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis
Pei Wang et al.
ONCOTARGETS AND THERAPY (2017)
MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer
Huaqi Wang et al.
Oncotarget (2017)
MALAT1-miR-101-SOX9 feedback loop modulates the chemo-resistance of lung cancer cell to DDP via Wnt signaling pathway
Wei Chen et al.
ONCOTARGET (2017)
Aberrant Long Noncoding RNAs Expression Profiles Affect Cisplatin Resistance in Lung Adenocarcinoma
Lijuan Hu et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Platinum drugs: from Pt(II) compounds, Pt(IV) prodrugs, to Pt nanocrystals/nanoclusters
Xi Hu et al.
SCIENCE BULLETIN (2017)
Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells
Dongya Zhang et al.
SCIENTIFIC REPORTS (2017)
LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4
Baoli Hu et al.
CANCER BIOLOGY & THERAPY (2017)
miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1
Haifeng Zhang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
MicroRNA-106b-5p regulates cisplatin chemosensitivity by targeting polycystic kidney disease-2 in non-small-cell lung cancer
Shaorong Yu et al.
ANTI-CANCER DRUGS (2017)
Drug Delivery Strategies for Platinum-Based Chemotherapy
Richard J. Browning et al.
ACS NANO (2017)
Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J
Lin Shi et al.
BMC CANCER (2017)
Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells
Shun Fang et al.
LABORATORY INVESTIGATION (2016)
MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2
Jing Xie et al.
TUMOR BIOLOGY (2016)
miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9
Lin Wu et al.
ONCOLOGY LETTERS (2016)
MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
Weili Li et al.
CANCER CELL INTERNATIONAL (2016)
Platinum-based drugs: past, present and future
Shahana Dilruba et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
MicroRNA-21 Regulates Non-Small Cell Lung Cancer Cell Invasion and Chemo-Sensitivity through SMAD7
Lei Lin et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1
Dezhi Cheng et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2
Min-Che Tung et al.
ONCOTARGET (2016)
Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2
Zhiqiang Ye et al.
ONCOTARGET (2016)
miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin
Xuesong Chen et al.
SCIENTIFIC REPORTS (2016)
The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer
Jian Zhao et al.
BMC CANCER (2015)
miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells
Z. Zhao et al.
CANCER GENE THERAPY (2015)
MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells
Paul Zarogoulidis et al.
CELLULAR SIGNALLING (2015)
Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links
Akshada Sawant et al.
DNA REPAIR (2015)
Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy
Helen H. W. Chen et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression
Chengguang Sui et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway
Yang Xia et al.
MOLECULAR MEDICINE REPORTS (2015)
The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer
Yu Fujita et al.
MOLECULAR THERAPY (2015)
Effect of microRNA-21 on multidrug resistance reversal in A549/DDP human lung cancer cells
Zuoliang Dong et al.
MOLECULAR MEDICINE REPORTS (2015)
Modulation of NF-κB/miR-21/PTEN Pathway Sensitizes Non-Small Cell Lung Cancer to Cisplatin
Zhenhua Yang et al.
PLOS ONE (2015)
The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma
Jing Liu et al.
PLOS ONE (2015)
MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC
Xiaoyuan Wang et al.
SCIENTIFIC REPORTS (2015)
MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G1/S transition and apoptosis by targeting p21WAF1/CIP1
H. Wang et al.
BRITISH JOURNAL OF CANCER (2014)
MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9
Zhuo Dong et al.
CANCER LETTERS (2014)
Decreased Expression of miR216a Contributes to Non-Small-Cell Lung Cancer Progression
Ren-Tao Wang et al.
CLINICAL CANCER RESEARCH (2014)
MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4
Fang-ling Ning et al.
DIAGNOSTIC PATHOLOGY (2014)
MicroRNA-449a inhibits cell growth in lung cancer and regulates long noncoding RNA nuclear enriched abundant transcript 1
J. You et al.
INDIAN JOURNAL OF CANCER (2014)
miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells
Jipeng Li et al.
MOLECULAR CANCER (2014)
miRNA 17 Family Regulates Cisplatin-Resistant and Metastasis by Targeting TGFbetaR2 in NSCLC (Publication with Expression of Concern. See vol. 14, 2019)
Zeyong Jiang et al.
PLOS ONE (2014)
Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition
Qiong Wang et al.
ONCOTARGET (2014)
Carboplatin: molecular mechanisms of action associated with chemoresistance
Graziele Fonseca de Sousa et al.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy
En-hai Cui et al.
ACTA PHARMACOLOGICA SINICA (2013)
DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
Wynand P. Roos et al.
CANCER LETTERS (2013)
miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2
Tianzhu Qiu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs
Aamir Ahmad et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
miR-135a/b Modulate Cisplatin Resistance of Human Lung Cancer Cell Line by Targeting MCL1
Li Zhou et al.
PATHOLOGY & ONCOLOGY RESEARCH (2013)
The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell
Yong Yang et al.
PLOS ONE (2013)
The Long Noncoding RNA HOTAIR Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma Cells via downregualtion of p21WAF1/CIP1 Expression
Zhili Liu et al.
PLOS ONE (2013)
miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP
Wei Zhu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression
Y-S Zang et al.
CANCER GENE THERAPY (2012)
Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
Michael R. Green et al.
CLINICAL CANCER RESEARCH (2012)
Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
Akiko Kuwahara et al.
International Journal of Medical Sciences (2012)
miR-513a-3p sensitizes human lung adenocarcinoma cells to chemotherapy by targeting GSTP1
Xuelin Zhang et al.
LUNG CANCER (2012)
Alterations of microRNAs in Cisplatin-resistant Human Non-small Cell Lung Cancer Cells (A549/DDP)
Qi Wang et al.
EXPERIMENTAL LUNG RESEARCH (2011)
Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)
Hai-Bo Bian et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial J. Wheate et al.
DALTON TRANSACTIONS (2010)
miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
Wei Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
p21 in cancer: intricate networks and multiple activities
Tarek Abbas et al.
NATURE REVIEWS CANCER (2009)
Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells
Hua Zhu et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Cell cycle control as a basis for cancer chemoprevention through dietary agents
Syed Musthapa Meeran et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy
P. Wynne et al.
BRITISH JOURNAL OF CANCER (2007)
Kinetics of carboplatin-DNA binding in genomic DNA and bladder cancer cells as determined by accelerator mass spectrometry
Sang Soo Hah et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2006)
Platinum anticancer drug damage enforces a particular rotational setting of DNA in nucleosomes
AJ Danford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Recognition of cisplatin adducts by cellular proteins
M Kartalou et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Oxaliplatin-induced damage of cellular DNA
JM Woynarowski et al.
MOLECULAR PHARMACOLOGY (2000)
分享论文
